Hemagen Diagnostics, Inc. (HMGN)

Market Cap	3.10K -98.7%
Revenue (ttm)	4.04M -21.4%
Net Income	-907.32K
EPS	-0.06
Shares Out	15.50M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,710
Open	0.0002
Previous Close	n/a
Day's Range	0.0002 - 0.0002
52-Week Range	0.0001 - 0.1251
Beta	1,150.59
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Hemagen Diagnostics

Hemagen Diagnostics, Inc. provides human and veterinary diagnostic services worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its proprietary test kits are used to aid in the diagnosis of certain autoimmune and infectious diseases. It also provides human diagnostics, such as universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1985
• Employees: 15
• Stock Exchange: OTCMKTS
• Ticker Symbol: HMGN

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 30, 2026

Data Sources Report a data error